Clinical Trial Update: Antimicrobial Resistant Organism Decolonization After Microbiome Perturbation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial on decolonization of antimicrobial-resistant organisms after microbiome perturbation was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antibiotic-resistant Infection
• Gram-negative Bacteremia

Snippet

Sponsor: University Health Network, Toronto | Conditions: Gram-negative Bacteremia, Microbial Colonization | Phase 2 | Status: WITHDRAWN